Please assess the completion status of the following clinical trial:

Trial Title: A Study of Administration of Trastuzumab (Herceptin) by a Single-use Injection Device Versus a Handheld Syringe

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy male patients, 18 to 45 years of age, inclusive~* No history of hypersensitivity or allergic reactions following drug administration~* No history of clinically significant or clinically relevant cardiac condition~* No history of previous anticancer treatment~* Body mass index (BMI) between 18-32 kg/m2, inclusive~Exclusion Criteria:~* Positive test result for drugs of abuse~* Positive test result for hepatitis B, hepatitis C, or HIV 1 or 2~* Systolic blood pressure greater than 140 mmHG or less than 90 mmHG, or diastolic blood pressure greater than 90 mmHG or less than 50 mmHG~* Clinically significant abnormal laboratory values

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).